SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001144204-12-020459
Filing Date
2012-04-05
Accepted
2012-04-05 20:01:42
Documents
1
Period of Report
2012-04-05
Filing Date Changed
2012-04-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v308674_4.html 4  
1 OWNERSHIP DOCUMENT v308674_4.xml 4 3742
  Complete submission text file 0001144204-12-020459.txt   5025
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Oliviero James F III (Reporting) CIK: 0001434718 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 12746896